Aclaris Therapeutics Statistics

Total Valuation

ACRS has a market cap or net worth of $184.16 million. The enterprise value is $5.64 million.

Market Cap	184.16M
Enterprise Value	5.64M

Important Dates

The last earnings date was Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

ACRS has 108.33 million shares outstanding. The number of shares has increased by 44.96% in one year.

Current Share Class	108.33M
Shares Outstanding	108.33M
Shares Change (YoY)	+44.96%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	2.69%
Owned by Institutions (%)	62.27%
Float	72.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.42
Forward PS	36.80
PB Ratio	1.40
P/TBV Ratio	1.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.34
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.88, with a Debt / Equity ratio of 0.02.

Current Ratio	3.88
Quick Ratio	3.73
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -101.41% and return on invested capital (ROIC) is -26.98%.

Return on Equity (ROE)	-101.41%
Return on Assets (ROA)	-20.86%
Return on Invested Capital (ROIC)	-26.98%
Return on Capital Employed (ROCE)	-36.00%
Revenue Per Employee	$262,328
Profits Per Employee	-$2.10M
Employee Count	64
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +49.12% in the last 52 weeks. The beta is 0.31, so ACRS's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	+49.12%
50-Day Moving Average	1.54
200-Day Moving Average	2.00
Relative Strength Index (RSI)	64.88
Average Volume (20 Days)	1,425,489

Short Selling Information

The latest short interest is 6.55 million, so 6.05% of the outstanding shares have been sold short.

Short Interest	6.55M
Short Previous Month	7.78M
Short % of Shares Out	6.05%
Short % of Float	9.02%
Short Ratio (days to cover)	5.12

Income Statement

In the last 12 months, ACRS had revenue of $16.79 million and -$134.65 million in losses. Loss per share was -$1.31.

Revenue	16.79M
Gross Profit	-36.30M
Operating Income	-58.43M
Pretax Income	-134.65M
Net Income	-134.65M
EBITDA	-58.26M
EBIT	-58.43M
Loss Per Share	-$1.31

Full Income Statement

Balance Sheet

The company has $99.81 million in cash and $2.37 million in debt, giving a net cash position of $178.52 million or $1.65 per share.

Cash & Cash Equivalents	99.81M
Total Debt	2.37M
Net Cash	178.52M
Net Cash Per Share	$1.65
Equity (Book Value)	131.74M
Book Value Per Share	1.22
Working Capital	77.36M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$9.99 million and capital expenditures -$64,000, giving a free cash flow of -$10.05 million.

Operating Cash Flow	-9.99M
Capital Expenditures	-64,000
Free Cash Flow	-10.05M
FCF Per Share	-$0.09

Full Cash Flow Statement

Margins

Gross Margin	-216.22%
Operating Margin	-348.04%
Pretax Margin	-802.03%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ACRS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-44.96%
Shareholder Yield	-44.96%
Earnings Yield	-73.11%
FCF Yield	-5.46%

Analyst Forecast

The average price target for ACRS is $9.25, which is 444.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.25
Price Target Difference	444.12%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	25.46%
EPS Growth Forecast (5Y)	-15.09%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ACRS has an Altman Z-Score of -5.54 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.54
Piotroski F-Score	1